APQ Guide: Management Responsibilities & Review (MRR)

Digital Only

Member Price
$215.00 / €195.00
Non-Member Price
$515.00 / €468.00

Published: July 2021
Pages: 162

ICH Q10 sets a clear expectation regarding the role of strong leadership in terms of demonstrating and communicating “strong and visible support for the pharmaceutical quality system.” The ISPE APQ Guide: Management Responsibilities and Management Review provides a quality management framework for assessing and advancing leadership systems. It provides a systematic and proactive approach to evaluating management responsibilities highlighted in ICH Q10 as well as other key leadership components:

  • Patient/Consumer Focus
  • Management Commitment
  • Quality Planning
  • Internal Communication
  • Management of Outsourced Activities and Purchased Materials
  • Management of Change in Product Ownership
  • Regulatory and Industry Awareness

The ISPE APQ Guide: Management Responsibilities and Management Review is the second publication in the APQ Guide series that seeks to improve the state of pharmaceutical quality and ensure sustainable compliance. The Guide Series is part of ISPE’s initiative, Advancing Pharmaceutical Quality (APQ), a comprehensive program for assessing and improving an organization’s quality management maturity.

Note: Each Guide in the APQ Guide series contains two parts. Part 1 covers the key principles of the APQ program and explains the Assess, Aspire, Act, and Advance framework. This prerequisite information is applicable to all PQS elements and is common across each of the APQ Guides. Part 2 of the ISPE APQ Guide: Management Responsibilities and Management Review covers the practical application of the APQ framework to leadership.

Built upon the ICH Q10 Pharmaceutical Quality System (PQS) model, the APQ program is an industry-led approach that seeks to advance pharmaceutical quality beyond the submission of data for harmonized, reportable metrics. The program is aligned with international initiatives that promote quality excellence, as well as with the FDA’s interest in quality management maturity and rating the maturity of manufacturing facilities, as cited in their 2019 Drug Shortages report. The result is a program that organizations can leverage to ensure a continuous supply of quality medicines to patients.

The APQ Guide Series provides a practical set of tools and systematic approaches for organizations to proactively advance the maturity and effectiveness of the following PQS elements:

  • Corrective and Preventive Action system
  • Management responsibilities and management review
  • Change management system
  • Process performance and product quality monitoring system

Each area will be covered in depth using the APQ framework of Assess, Aspire, Act, and Advance, providing tools and Key Performance Indicators (KPIs) for organizations to incorporate into their quality program. Each Guide contains quantitative and qualitative tools to assess the organization’s current state of quality, diagnose gaps, and identify improvement targets – Assess and Aspire. The Guides will discuss using this information to develop an Improvement Action Plan that the organization can execute and evaluate for effectiveness – Act and Advance. The ISPE APQ Guide: Management Responsibilities and Management Review focuses specifically on application of the APQ framework to leadership systems.


Guide Core Team

Steven A. Greer
Leadership Coach, GMP Consultant
Engineering Systems Inc.
Co-Lead
Michael Grischeau
Director of Data Analytics & Management Review
AbbVie Inc
Co-Lead
Placeholder Person Graphic
Tisha Cromwell
Director of Quality Assurance
GlaxoSmithKline
Tami J. Frederick
Senior Director, Corporate Quality Systems & Cultural Excellence
Perrigo
Marci L. Goldfinger
Global Director, Consumer Health Quality Strategy
Johnson & Johnson
Robert E. Matje, CPIP, PE
Principal
RemTech, LLC
Lorraine E. McClain
Quality Consultant
Nabriva Therapeutics
Placeholder Person Graphic
Jo Anne Valentino
Global Head of Quality / VP
Minaris Regenerative Medicine, LLC
Veda K. Walcott
Vice President Regulatory Affairs & Compliance
Catalent Pharma Solutions
Bryan Winship
Head of Strategic Projects and PMO Bioscience Global Operations
Lonza
Nuala F. Calnan, PhD
CEO
Biopharm Excel Ltd
Christopher John Potter, Ph.D.
CMC Pharmaceutical Consultant